Cargando…

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia

Detalles Bibliográficos
Autores principales: Stanulla, Martin, Schewe, Denis M., Bornhauser, Beat, Bourquin, Jean-Pierre, Eckert, Cornelia, Eberl, Wolfgang, Wolf, Saskia, Wolf, Julian, Vogiatzi, Fotini, Bergmann, Anke K., Cario, Gunnar, Beier, Rita, Sauer, Martin, Kratz, Christian P., Maecker-Kolhoff, Britta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977701/
https://www.ncbi.nlm.nih.gov/pubmed/36651980
http://dx.doi.org/10.1007/s00277-023-05083-y
_version_ 1784899353503072256
author Stanulla, Martin
Schewe, Denis M.
Bornhauser, Beat
Bourquin, Jean-Pierre
Eckert, Cornelia
Eberl, Wolfgang
Wolf, Saskia
Wolf, Julian
Vogiatzi, Fotini
Bergmann, Anke K.
Cario, Gunnar
Beier, Rita
Sauer, Martin
Kratz, Christian P.
Maecker-Kolhoff, Britta
author_facet Stanulla, Martin
Schewe, Denis M.
Bornhauser, Beat
Bourquin, Jean-Pierre
Eckert, Cornelia
Eberl, Wolfgang
Wolf, Saskia
Wolf, Julian
Vogiatzi, Fotini
Bergmann, Anke K.
Cario, Gunnar
Beier, Rita
Sauer, Martin
Kratz, Christian P.
Maecker-Kolhoff, Britta
author_sort Stanulla, Martin
collection PubMed
description
format Online
Article
Text
id pubmed-9977701
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99777012023-03-03 Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia Stanulla, Martin Schewe, Denis M. Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Eberl, Wolfgang Wolf, Saskia Wolf, Julian Vogiatzi, Fotini Bergmann, Anke K. Cario, Gunnar Beier, Rita Sauer, Martin Kratz, Christian P. Maecker-Kolhoff, Britta Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-01-18 2023 /pmc/articles/PMC9977701/ /pubmed/36651980 http://dx.doi.org/10.1007/s00277-023-05083-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Stanulla, Martin
Schewe, Denis M.
Bornhauser, Beat
Bourquin, Jean-Pierre
Eckert, Cornelia
Eberl, Wolfgang
Wolf, Saskia
Wolf, Julian
Vogiatzi, Fotini
Bergmann, Anke K.
Cario, Gunnar
Beier, Rita
Sauer, Martin
Kratz, Christian P.
Maecker-Kolhoff, Britta
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title_full Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title_fullStr Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title_full_unstemmed Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title_short Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
title_sort molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977701/
https://www.ncbi.nlm.nih.gov/pubmed/36651980
http://dx.doi.org/10.1007/s00277-023-05083-y
work_keys_str_mv AT stanullamartin molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT schewedenism molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT bornhauserbeat molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT bourquinjeanpierre molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT eckertcornelia molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT eberlwolfgang molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT wolfsaskia molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT wolfjulian molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT vogiatzifotini molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT bergmannankek molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT cariogunnar molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT beierrita molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT sauermartin molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT kratzchristianp molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia
AT maeckerkolhoffbritta molecularcompleteremissionfollowingcombinationtreatmentofdaratumumabandvenetoclaxinanadolescentwithrelapsedmixedphenotypeacuteleukemia